Visfatin: A possible role in cardiovasculo-metabolic disorders

Ali Dakroub; Suzanne A. Nasser; Nour Younis; Humna Bhagani; Yusra Al-Dhaheri; Gianfranco Pintus; Assaad A. Eid; Ahmed F. El-Yazbi; Ali H. Eid

doi:10.3390/cells9112444

Visfatin: A possible role in cardiovasculo-metabolic disorders

Ali Dakroub, Suzanne A. Nasser, Nour Younis, Humna Bhagani, Yusra Al-Dhaheri, Gianfranco Pintus, Assaad A. Eid, Ahmed F. El-Yazbi, Ali H. Eid

Department of Biology

Research output: Contribution to journal › Review article › peer-review

79 Citations (Scopus)

Abstract

Visfatin/NAMPT (nicotinamide phosphoribosyltransferase) is an adipocytokine with several intriguing properties. It was first identified as pre-B-cell colony-enhancing factor but turned out to possess enzymatic functions in nicotinamide adenine dinucleotide biosynthesis, with ubiquitous expression in skeletal muscles, liver, cardiomyocytes, and brain cells. Visfatin exists in an intracellular (iNAMPT) and extracellular (eNAMPT) form. Intracellularly, visfatin/iNAMPT plays a regulatory role in NAD⁺ biosynthesis and thereby affects many NAD-dependent proteins such as sirtuins, PARPs, MARTs and CD38/157. Extracellularly, visfatin is associated with many hormone-like signaling pathways and activates some intracellular signaling cascades. Importantly, eNAMPT has been associated with several metabolic disorders including obesity and type 1 and 2 diabetes. In this review, a brief overview about visfatin is presented with special emphasis on its relevance to metabolic diseases. Visfatin/NAMPT appears to be a unique molecule with clinical significance with a prospective promising diagnostic, prognostic, and therapeutic applications in many cardiovasculo-metabolic disorders.

Original language	English
Article number	2444
Pages (from-to)	1-19
Number of pages	19
Journal	Cells
Volume	9
Issue number	11
DOIs	https://doi.org/10.3390/cells9112444
Publication status	Published - Nov 2020

Keywords

Metabolic disorders
NAD
PARPs/MARTs
Sirtuins
Visfatin/NAMPT

ASJC Scopus subject areas

General Biochemistry,Genetics and Molecular Biology

Access to Document

10.3390/cells9112444

Cite this

@article{f89a34b73f2c4cc187880ed48cc75774,

title = "Visfatin: A possible role in cardiovasculo-metabolic disorders",

abstract = "Visfatin/NAMPT (nicotinamide phosphoribosyltransferase) is an adipocytokine with several intriguing properties. It was first identified as pre-B-cell colony-enhancing factor but turned out to possess enzymatic functions in nicotinamide adenine dinucleotide biosynthesis, with ubiquitous expression in skeletal muscles, liver, cardiomyocytes, and brain cells. Visfatin exists in an intracellular (iNAMPT) and extracellular (eNAMPT) form. Intracellularly, visfatin/iNAMPT plays a regulatory role in NAD+ biosynthesis and thereby affects many NAD-dependent proteins such as sirtuins, PARPs, MARTs and CD38/157. Extracellularly, visfatin is associated with many hormone-like signaling pathways and activates some intracellular signaling cascades. Importantly, eNAMPT has been associated with several metabolic disorders including obesity and type 1 and 2 diabetes. In this review, a brief overview about visfatin is presented with special emphasis on its relevance to metabolic diseases. Visfatin/NAMPT appears to be a unique molecule with clinical significance with a prospective promising diagnostic, prognostic, and therapeutic applications in many cardiovasculo-metabolic disorders.",

keywords = "Metabolic disorders, NAD, PARPs/MARTs, Sirtuins, Visfatin/NAMPT",

author = "Ali Dakroub and Nasser, {Suzanne A.} and Nour Younis and Humna Bhagani and Yusra Al-Dhaheri and Gianfranco Pintus and Eid, {Assaad A.} and El-Yazbi, {Ahmed F.} and Eid, {Ali H.}",

note = "Publisher Copyright: {\textcopyright} 2020 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2020",

month = nov,

doi = "10.3390/cells9112444",

language = "English",

volume = "9",

pages = "1--19",

journal = "Cells",

issn = "2073-4409",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "11",

}

TY - JOUR

T1 - Visfatin

T2 - A possible role in cardiovasculo-metabolic disorders

AU - Dakroub, Ali

AU - Nasser, Suzanne A.

AU - Younis, Nour

AU - Bhagani, Humna

AU - Al-Dhaheri, Yusra

AU - Pintus, Gianfranco

AU - Eid, Assaad A.

AU - El-Yazbi, Ahmed F.

AU - Eid, Ali H.

PY - 2020/11

Y1 - 2020/11

N2 - Visfatin/NAMPT (nicotinamide phosphoribosyltransferase) is an adipocytokine with several intriguing properties. It was first identified as pre-B-cell colony-enhancing factor but turned out to possess enzymatic functions in nicotinamide adenine dinucleotide biosynthesis, with ubiquitous expression in skeletal muscles, liver, cardiomyocytes, and brain cells. Visfatin exists in an intracellular (iNAMPT) and extracellular (eNAMPT) form. Intracellularly, visfatin/iNAMPT plays a regulatory role in NAD+ biosynthesis and thereby affects many NAD-dependent proteins such as sirtuins, PARPs, MARTs and CD38/157. Extracellularly, visfatin is associated with many hormone-like signaling pathways and activates some intracellular signaling cascades. Importantly, eNAMPT has been associated with several metabolic disorders including obesity and type 1 and 2 diabetes. In this review, a brief overview about visfatin is presented with special emphasis on its relevance to metabolic diseases. Visfatin/NAMPT appears to be a unique molecule with clinical significance with a prospective promising diagnostic, prognostic, and therapeutic applications in many cardiovasculo-metabolic disorders.

AB - Visfatin/NAMPT (nicotinamide phosphoribosyltransferase) is an adipocytokine with several intriguing properties. It was first identified as pre-B-cell colony-enhancing factor but turned out to possess enzymatic functions in nicotinamide adenine dinucleotide biosynthesis, with ubiquitous expression in skeletal muscles, liver, cardiomyocytes, and brain cells. Visfatin exists in an intracellular (iNAMPT) and extracellular (eNAMPT) form. Intracellularly, visfatin/iNAMPT plays a regulatory role in NAD+ biosynthesis and thereby affects many NAD-dependent proteins such as sirtuins, PARPs, MARTs and CD38/157. Extracellularly, visfatin is associated with many hormone-like signaling pathways and activates some intracellular signaling cascades. Importantly, eNAMPT has been associated with several metabolic disorders including obesity and type 1 and 2 diabetes. In this review, a brief overview about visfatin is presented with special emphasis on its relevance to metabolic diseases. Visfatin/NAMPT appears to be a unique molecule with clinical significance with a prospective promising diagnostic, prognostic, and therapeutic applications in many cardiovasculo-metabolic disorders.

KW - Metabolic disorders

KW - NAD

KW - PARPs/MARTs

KW - Sirtuins

KW - Visfatin/NAMPT

UR - http://www.scopus.com/inward/record.url?scp=85096083087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85096083087&partnerID=8YFLogxK

U2 - 10.3390/cells9112444

DO - 10.3390/cells9112444

M3 - Review article

C2 - 33182523

AN - SCOPUS:85096083087

SN - 2073-4409

VL - 9

SP - 1

EP - 19

JO - Cells

JF - Cells

IS - 11

M1 - 2444

ER -

Visfatin: A possible role in cardiovasculo-metabolic disorders

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this